Baird Capital

Portfolio Co Investors 2026 for Baird Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Baird Capital accounts for 7 tracked companies with verified cap-table data, 7 of which disclose round sizes totalling $497M. The median disclosed raise is $44M, and the largest is Greenlight Biosciences at $277M, ahead of NeoChord ($71M) and Quiq ($48M).

The names that recur most often on these co-invested cap tables are Baird Capital (7 companies), Jason Dinges (1 company), Maveron (1 company), OAK HC/FT (1 company), Tsvc Capital (1 company), Continental Grain Company (1 company). By latest disclosed round, the market skews Series C (2), Series B (2), Convertible Debt (1), Series A (1).

Best funded Baird Capital companies

  1. Greenlight Biosciences — $277M (latest: Series C)
  2. NeoChord — $71M (latest: Convertible Debt)
  3. Quiq — $48M (latest: Series C)
  4. Osano — $44M (latest: Series B)
  5. Autobooks — $23M (latest: Series A)
  6. Xinma Bio — $21M (latest: Series B)
  7. High Street Partners — $14M (latest: Growth)

Baird Capital — related firms and companies (49)

Baird Capital profile · All research reports